FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009133033> ?p ?o ?g. }

• W3009133033 endingPage "87" @default.
• W3009133033 startingPage "81" @default.
• W3009133033 abstract "Significant benefit of intravenous ferric carboxymaltose (FCM) treatment for restless legs syndrome (RLS) has been well-established. However, no clinical indicators predicting treatment response of RLS have been established. This study aimed to determine factors predicting outcome of clinical FCM treatment of RLS patients. Data were retrospectively reviewed from all patients who received FCM treatment for RLS from April 2016 to April 2019. These data included: detailed history, international RLS scale score (IRLS), questionnaires, comorbidity, and previous RLS medication use. Morning fasting serum iron, ferritin, and total iron-binding capacity were measured before and at four weeks after treatment. RLS patients with possible secondary RLS were identified by reviewing the medical histories. This included patients with iron deficiency anemia, lumbosacral radiculopathy, and gastrectomy. Primary RLS included those with no indication of secondary medical factors contributing to RLS. Treatment response was assessed using the IRLS and clinical ratings at four weeks after FCM administration. Patients with a greater than 40% decrease in IRLS were classified as responders. The study comprised 164 patients with IRLS and clinical ratings obtained before and at four weeks after intravenous (IV) iron. Treatment responses differed considerably between diagnostic groups of RLS. Percentage responding was: 64.7% (66 of 102) for patients with primary RLS, 90.9% (10 of 11) with gastrectomy, 91.3% (21 of 23) with iron deficiency anemia and 39.3% (11 of 28) with lumbosacral radiculopathy. When responders were compared to non-responders in primary RLS patients, responders had significantly lower serum iron (80.5 ± 26.7 vs. 95.8 ± 30.5 μg/dL, p = 0.022) and percentage transferrin saturation (%TSAT) (25.4 ± 9.6 vs. 30.5 ± 10.5%, p = 0.026) in females, but not males. Logistic regression controlling for major subject variables showed that %TSAT significantly predicted response. (odds ratio [OR]: 0.955, confidence interval: 0.913–0.998, p = 0.040). Intravenous FCM in moderate to severe RLS patients is beneficial as a first-line or add-on treatment, particularly for patients with compromised peripheral iron state. Overall, lower %TSAT predicted better chance of responding to the IV iron treatment especially for females." @default.
• W3009133033 created "2020-03-13" @default.
• W3009133033 creator A5009516582 @default.
• W3009133033 creator A5034813638 @default.
• W3009133033 creator A5037770900 @default.
• W3009133033 creator A5044121460 @default.
• W3009133033 date "2020-11-01" @default.
• W3009133033 modified "2023-10-01" @default.
• W3009133033 title "Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome" @default.
• W3009133033 cites W1916272488 @default.
• W3009133033 cites W1965146150 @default.
• W3009133033 cites W1985237673 @default.
• W3009133033 cites W1991348233 @default.
• W3009133033 cites W2005387985 @default.
• W3009133033 cites W2019128683 @default.
• W3009133033 cites W2019728909 @default.
• W3009133033 cites W2022377540 @default.
• W3009133033 cites W2048124910 @default.
• W3009133033 cites W2055064539 @default.
• W3009133033 cites W2059230191 @default.
• W3009133033 cites W2062745848 @default.
• W3009133033 cites W2062784137 @default.
• W3009133033 cites W2091171245 @default.
• W3009133033 cites W2116642832 @default.
• W3009133033 cites W2147694941 @default.
• W3009133033 cites W2157103725 @default.
• W3009133033 cites W2157336209 @default.
• W3009133033 cites W2170773352 @default.
• W3009133033 cites W2508442572 @default.
• W3009133033 cites W2551881775 @default.
• W3009133033 cites W2669264138 @default.
• W3009133033 cites W2770403954 @default.
• W3009133033 cites W2774596918 @default.
• W3009133033 cites W76459356 @default.
• W3009133033 doi "https://doi.org/10.1016/j.sleep.2020.02.027" @default.
• W3009133033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32853922" @default.
• W3009133033 hasPublicationYear "2020" @default.
• W3009133033 type Work @default.
• W3009133033 sameAs 3009133033 @default.
• W3009133033 citedByCount "5" @default.
• W3009133033 countsByYear W30091330332021 @default.
• W3009133033 countsByYear W30091330332022 @default.
• W3009133033 crossrefType "journal-article" @default.
• W3009133033 hasAuthorship W3009133033A5009516582 @default.
• W3009133033 hasAuthorship W3009133033A5034813638 @default.
• W3009133033 hasAuthorship W3009133033A5037770900 @default.
• W3009133033 hasAuthorship W3009133033A5044121460 @default.
• W3009133033 hasConcept C118552586 @default.
• W3009133033 hasConcept C126322002 @default.
• W3009133033 hasConcept C16568411 @default.
• W3009133033 hasConcept C2776732101 @default.
• W3009133033 hasConcept C2776750294 @default.
• W3009133033 hasConcept C2777417653 @default.
• W3009133033 hasConcept C2778248108 @default.
• W3009133033 hasConcept C2779159551 @default.
• W3009133033 hasConcept C71924100 @default.
• W3009133033 hasConcept C90924648 @default.
• W3009133033 hasConceptScore W3009133033C118552586 @default.
• W3009133033 hasConceptScore W3009133033C126322002 @default.
• W3009133033 hasConceptScore W3009133033C16568411 @default.
• W3009133033 hasConceptScore W3009133033C2776732101 @default.
• W3009133033 hasConceptScore W3009133033C2776750294 @default.
• W3009133033 hasConceptScore W3009133033C2777417653 @default.
• W3009133033 hasConceptScore W3009133033C2778248108 @default.
• W3009133033 hasConceptScore W3009133033C2779159551 @default.
• W3009133033 hasConceptScore W3009133033C71924100 @default.
• W3009133033 hasConceptScore W3009133033C90924648 @default.
• W3009133033 hasLocation W30091330331 @default.
• W3009133033 hasOpenAccess W3009133033 @default.
• W3009133033 hasPrimaryLocation W30091330331 @default.
• W3009133033 hasRelatedWork W1971200817 @default.
• W3009133033 hasRelatedWork W2004573299 @default.
• W3009133033 hasRelatedWork W2021754302 @default.
• W3009133033 hasRelatedWork W2059743651 @default.
• W3009133033 hasRelatedWork W2061343662 @default.
• W3009133033 hasRelatedWork W2091171245 @default.
• W3009133033 hasRelatedWork W2156391479 @default.
• W3009133033 hasRelatedWork W2170800701 @default.
• W3009133033 hasRelatedWork W2800589543 @default.
• W3009133033 hasRelatedWork W2907446554 @default.
• W3009133033 hasVolume "75" @default.
• W3009133033 isParatext "false" @default.
• W3009133033 isRetracted "false" @default.
• W3009133033 magId "3009133033" @default.
• W3009133033 workType "article" @default.